Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

by Elana GotkineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea comp

Updated on: August 06,2024 0

Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

by Elana GotkineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea comp

Updated on:August 06,2024 0

Prevalence of skin cancer varies for sexual minority, heterosexual adults

by Elana GotkineWith respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published

Updated on: July 23,2024 0

Prevalence of skin cancer varies for sexual minority, heterosexual adults

by Elana GotkineWith respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published

Updated on:July 23,2024 0

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432

Updated on: July 31,2024 0

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432

Updated on:July 31,2024 0

AI tool could dramatically decrease diagnostic times for psoriatic arthritis patients

by European Academy of Dermatology and VenereologyCredit: Unsplash/CC0 Public DomainResearchers in Israel have shown that a new machine-learning tool can speed up the diagnosis of psoriatic arthritis

Updated on: July 03,2024 3

AI tool could dramatically decrease diagnostic times for psoriatic arthritis patients

by European Academy of Dermatology and VenereologyCredit: Unsplash/CC0 Public DomainResearchers in Israel have shown that a new machine-learning tool can speed up the diagnosis of psoriatic arthritis

Updated on:July 03,2024 3

The dirty business of beauty | DW Documentary

Updated on: September 05,2024 0

The dirty business of beauty | DW Documentary

Updated on:September 05,2024 0

8 Reasons Why You Might be Losing Hair

Updated on: July 24,2024 0

8 Reasons Why You Might be Losing Hair

Updated on:July 24,2024 0

FDA approves Nemluvio for moderate-to-severe atopic dermatitis

FDA approves Nemluvio for moderate-to-severe atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-s

Updated on: January 06,2025 0

FDA approves Nemluvio for moderate-to-severe atopic dermatitis

FDA approves Nemluvio for moderate-to-severe atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-s

Updated on:January 06,2025 0

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p

Updated on: July 17,2024 0

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p

Updated on:July 17,2024 0

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev

Updated on: June 01,2024 6

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev

Updated on:June 01,2024 6

Do skin moisturizers help prevent eczema in infants?

by WileyCredit: CC0 Public DomainAtopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children wor

Updated on: June 25,2024 8

Do skin moisturizers help prevent eczema in infants?

by WileyCredit: CC0 Public DomainAtopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children wor

Updated on:June 25,2024 8

Long-term upadacitinib use feasible for adolescents with atopic dermatitis

by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23

Updated on: November 13,2024 0

Long-term upadacitinib use feasible for adolescents with atopic dermatitis

by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23

Updated on:November 13,2024 0

10 Signs Your Body Is Begging for Vitamin D

Updated on: July 24,2024 0

10 Signs Your Body Is Begging for Vitamin D

Updated on:July 24,2024 0